Sign In
Search Icon
Menu Icon

COVID-19 Therapeutics Transition to Commercial Distribution: Frequently Asked Questions

April 10, 2024

Sunsetting the U.S. Government COVID-19 Therapeutics Distribution Program

This resource provides critical information on the transition of COVID-19 Therapeutics to the commercial market, including major milestones and dates, guidance on inventory disposal and management, data reporting requirements, and programs for uninsured and underinsured individuals.

Read the Guide

Frequently Asked Questions